معرفی
Aidan Bindoff is a Research Fellow at the Wicking Dementia Research Education Centre, University of Tasmania, with expertise in behavioral neuroscience and dementia research. His work primarily focuses on developing innovative digital screening tools for early detection of neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease, through analysis of motor and speech patterns.
Bindoff's research interests center on the preclinical detection of dementia using computerized analysis of hand movements, eye tracking, and speech patterns. His work explores how subtle motor and cognitive changes can serve as early biomarkers for neurodegenerative diseases, potentially enabling interventions years before traditional symptoms appear. He investigates the intersection of digital health technologies, behavioral neuroscience, and dementia prevention strategies, with particular attention to modifiable risk factors and population-level screening approaches.
His recent publications demonstrate a clear trajectory toward developing scalable, non-invasive screening tools for dementia risk. The research consistently focuses on translating laboratory findings into practical home-based assessments using smartphones and webcams. Key themes include the relationship between motor dysfunction and cognitive decline, sex-specific manifestations of sleep disorders related to neurodegeneration, and the impact of social determinants on dementia risk.
Bindoff has secured substantial research funding from multiple sources including the National Health & Medical Research Council (NHMRC), Clifford Craig Foundation, and Royal Hobart Hospital Research Foundation. His current major projects include 'Hiding in plain sight: Early identification of neurodegenerative disorders with computer analysis of face and eye movements' ($1,006,412) and 'The future in our hands: Screening for preclinical Alzheimer's disease by analysing hand movements' ($899,782), both running through 2028 and 2025 respectively.
He actively collaborates within the ISLAND (Island Study Linking Ageing and Neurodegenerative Disease) research initiative, contributing to multiple studies examining dementia risk factors in the Tasmanian population. His work bridges clinical neuroscience, digital health innovation, and public health approaches to dementia prevention.
